Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
Clinical trial NCT02587962 · TERMINATED
Trial details
- NCT number
- NCT02587962
- Sponsor
- Medivir
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-04
- Primary completion
- 2020-02-17
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.